The David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
The David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA; Division of Gastroenterology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Biomaterials. 2022 Sep;288:121703. doi: 10.1016/j.biomaterials.2022.121703. Epub 2022 Aug 17.
Intravesical instillation is an efficient drug delivery route for the local treatment of various urological conditions. Nevertheless, intravesical instillation is associated with several challenges, including pain, urological infection, and frequent clinic visits for catheterization; these difficulties support the need for a simple and easy intravesical drug delivery platform. Here, we propose a novel biodegradable intravesical device capable of long-term, local drug delivery without a retrieval procedure. The intravesical device is composed of drug encapsulating biodegradable polycaprolactone (PCL) microcapsules and connected by a bioabsorbable Polydioxanone (PDS) suture with NdFeB magnets in the end. The device is easily inserted into the bladder and forms a 'ring' shape optimized for maximal mechanical stability as informed by finite element analysis. In this study, inserted devices were retained in a swine model for 4 weeks. Using this device, we evaluated the system's capacity for delivery of lidocaine and resiquimod and demonstrated prolonged drug release. Moreover, a cost-effectiveness analysis supports device implementation compared to the standard of care. Our data support that this device can be a versatile drug delivery platform for urologic medications.
膀胱内灌注是一种有效的药物输送途径,可用于局部治疗各种泌尿科疾病。然而,膀胱内灌注存在一些挑战,包括疼痛、泌尿道感染和频繁到诊所进行导管插入;这些困难支持需要一个简单易用的膀胱内药物输送平台。在这里,我们提出了一种新的可生物降解的膀胱内装置,能够进行长期局部药物输送,无需取回程序。膀胱内装置由药物包封的可生物降解的聚己内酯(PCL)微胶囊组成,并通过末端带有 NdFeB 磁铁的可生物吸收的聚二氧杂环己酮(PDS)缝线连接。该装置易于插入膀胱,并形成一个“环”形,这是通过有限元分析告知的最大化机械稳定性的优化形状。在这项研究中,插入的装置在猪模型中保留了 4 周。使用该装置,我们评估了利多卡因和瑞喹莫德输送系统的能力,并证明了药物的延长释放。此外,成本效益分析支持与标准护理相比,该装置的实施。我们的数据支持该装置可以作为泌尿科药物的多功能药物输送平台。